Azurity Pharmaceuticals Announces Ferabright TM (ferumoxytol injection) Now Available in the U.S. for Magnetic Resonance Imaging of the Brain

Ferabright is the first and only iron-based contrast agent for MRI in the brainWoburn, MA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Azurity Pharmaceuticals, Inc. announced today that FerabrightTM ...
BioSpace

New indication in pediatric patients, including term neonates for Guerbet’s half-dose GBCA, Elucirem™ (Gadopiclenol) Injection

Guerbet's innovation, Elucirem™ is the first gadolinium-based contrast agent approved at half dose of gadolinium, and with the highest relaxivity, in comparison to other availab ...

FDA Approves VUEWAY® (gadopiclenol) Solution for Injection, Intravenous Use, for Use in Neonates and Infants

Bracco, a global leader in diagnostic imaging, today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Nasdaq

GE Healthcare Announces U.S. FDA Approval of Macrocyclic MRI Contrast Agent Clariscan™ (gadoterate meglumine) Injection for Intravenous Use

Clariscan, approved in more than 55 countries globally with over four million patient doses shipped, is now FDA-approved in the U.S. Expands the GE Healthcare portfolio of contrast media products “The ...
TCTMD

FDA Grants Cardiac MR Indication for Gadavist Contrast Injection

The FDA has granted expanded indications for use of gadobutrol (Gadavist; Bayer) injection, permitting its use in cardiac MR to assess myocardial perfusion and late gadolinium enhancement in adults ...
ascopubs.org

Doppler ultrasonography with perfusion software and contrast agent injection as a tool for early evaluation of metastatic renal cancers treated with the Raf kinase and VEGFR ...

Open label, randomized, phase II study of pertuzumab (P) in patients (pts) with metastatic breast cancer (MBC) with low expression of HER2 No significant financial relationships to disclose. This is ...
Business Wire

Fresenius Kabi Introduces Generic Iodixanol Contrast Media Agent

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it will introduce a portfolio of generic contrast media agents in the United States, starting immediately with the launch of ...
Hosted on MSN

Traces of Toxic Metals Can Linger in the Body After MRIs—A New Study Explains Why

When you get a magnetic resonance imaging (MRI) scan, you might get an injection of a contrast fluid called gadolinium, a kind of “dye” that highlights your organs, blood vessels, and tissues to ...
Nasdaq

FDA Okays Macrocyclic MRI Contrast Agent Clariscan Injection For Intravenous Use

(RTTNews) - GE Healthcare said Monday that the U.S. Food and Drug Administration approved Clariscan, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE Healthcare portfolio ...

New indication in pediatric patients, including term neonates for Guerbet's half-dose GBCA, Elucirem(TM) (Gadopiclenol) Injection

In the U.S., Elucirem is indicated in adults and now in pediatric patients including term neonates, for use with magnetic resonance imaging (MRI) to detect and visualize lesions with abnormal ...
Business Wire

GE Healthcare Announces U.S. FDA Approval of Macrocyclic MRI Contrast Agent Clariscan™ (gadoterate meglumine) Injection for Intravenous Use

CHALFONT ST GILES, England--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) has approved Clariscan™, a macrocyclic, ionic, gadolinium-based, MRI contrast agent, expanding the GE ...